EM

Eventide Management Partners

North America, Colorado, United States, Castle Rock

Description

Eventide is a private equity firm that identifies and invests in small to mid-sized companies in the market sectors.

Investor Profile

Eventide Management Partners has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eventide Management Partners frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Eisai
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
EC
North America, New York, United States, New York
Co-Investments: 1
Ono Venture Investment
North America, California, United States, San Francisco
Co-Investments: 1
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
The Column Group
North America, California, United States, San Francisco
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Eventide Management Partners?

Casma Therapeutics

Cambridge, Massachusetts, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

BiotechnologyHealth CareTherapeutics
Series CNov 15, 2022
Amount Raised: $46,000,000